Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement

Table 3 Accuracy of self-injectable epinephrine device demonstration (count and %)

Demonstration performed	Original EpiPen	New-look EpiPen	Anapen	Total	P value^*
	(n = 83)	(n = 87)	(n = 80)	(n = 250)
Step 1	69 (83.1)	76 (87.4)	75 (93.8)^a	222 (86.8)	0.11
Step 1	69 (83.1)	76 (87.4)	78 (97.5)^b	222 (86.8)	0.11
Step 2	80 (96.4)	84 (96.6)	76 (95)	240 (96.0)	0.86
Step 3	62 (74.7)	59 (67.8)	61 (76.3)	182 (72.8)	0.42
Step 4	8 (9.6)	26 (29.9)	18 (22.5)	52 (20.8)	0.005
Steps 1-3	50 (60.2)	54 (62.1)	59 (73.8)	163 (65.2)	0.15
Steps 1-4	8 (9.6)	21 (24.1)	17 (21.3)	46 (18.4)	0.04

^*Pearson chi-squared p-value for comparison of demonstration accuracy across groups. Step 1: Remove safety caps; Step 2: Place against mid-anterolateral thigh; Step 3: Push down hard/press red button to inject and hold for 10 seconds; Step 4: Remove device, avoid needle, massage site. ^aRemove black needle shield. ^bRemove gray safety cap from red button (Anapen only).

ISSN: 1710-1492